ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer
Zhe Tang(Zhejiang International Studies University), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Patrick G. Pilié(The University of Texas MD Anderson Cancer Center), Guang Peng(The University of Texas MD Anderson Cancer Center), Paul G. Corn(Cornell University), Timothy A. Yap(The University of Texas MD Anderson Cancer Center), Guang Yang(Jinan University), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Sanghee Park(Hanbat National University), Shan Peng(The University of Texas MD Anderson Cancer Center), Daoqi Wang(The University of Texas MD Anderson Cancer Center), Chuandong Geng(Baylor College of Medicine), Cheng Wu(Second Military Medical University)
Cited by 145
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k